eNews
Home page > Comments


Comments

Bayer's Nexavar meets goal in thyroid cancer trial

04.01.2013. | FRANKFURT (Reuters) - German drugmaker Bayer said its cancer treatment Nexavar reached a goal of improving the survival of patients with a certain type of thyroid cancer in a late-stage clinical trial....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: